Differential effect of materials for surface hemostasis on red blood cell morphology

Microscopy Research and Technique

Volumn 71, Issue 10, 2008, Pages 721-729

  Smith, Carr J ^a,b   Vournakis, John N ^b   Demcheva, Marina ^b   Fischer, Thomas H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Entegrion Inc ^*  (United States)

Author keywords

Hemostasis; Morphology; Poly N acetyl glucosamine; Red blood cell; Stomatocytic

Indexed keywords

BLOOD; CELLS; CHITOSAN; CYTOLOGY; GLUCOSAMINE; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; INTERFACES (MATERIALS); SCANNING ELECTRON MICROSCOPY;

ARTIFICIAL SURFACES; CELL MORPHOLOGY; COAGULATION PATHWAY; DIFFERENTIAL EFFECT; EFFECTS OF MATERIALS; HAEMOSTASIS; N ACETYLS; POLY-N-ACETYL GLUCOSAMINE; RED BLOOD CELL; STOMATOCYTIC;

MORPHOLOGY;

BETA POLY N ACETYLGLUCOSAMINE; CHITIN; CHITOSAN; N ACETYLGLUCOSAMINE; NANOFIBER; UNCLASSIFIED DRUG; POLY N ACETYL GLUCOSAMINE; POLY-N-ACETYL GLUCOSAMINE;

ARTICLE; BINDING AFFINITY; ERYTHROCYTE STRUCTURE; HEMOSTASIS; HUMAN; HUMAN CELL; MATERIALS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TOPICAL TREATMENT; TRANSMISSION ELECTRON MICROSCOPY; CELL ADHESION; DRUG EFFECT; ERYTHROCYTE; METABOLISM; ULTRASTRUCTURE;

ACETYLGLUCOSAMINE; CELL ADHESION; CHITIN; CHITOSAN; ERYTHROCYTES; HEMOSTASIS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 54449100273     PISSN: 1059910X     EISSN: 10970029     Source Type: Journal    
DOI: 10.1002/jemt.20612     Document Type: Article

References (63)

1. Alkhamis TM, Beissinger RL, Chediak JR. 1988. Red blood cell effect on platelet adhesion and aggregation in low-stress shear flow. Myth or fact? ASAIO Trans 34:868-873.
2. Alkhamis TM, Beissinger RL, Chediak JR. 1990. Artificial surface effect on red blood cells and platelets in laminar shear flow. Blood 75:1568-1575.
3. Armstrong JK, Meiselman HJ, Fisher TC. 1995. Inhibition of red blood cell-induced platelet aggregation in whole blood by a nonionic surfactant, poloxamer 188 (RheothRx injection). Thromb Res 79:437-450.
4. Barr H. 1941. The stickiness of platelets. Lancet 238:609-610.
5. Bell DN, Spain S, Goldsmith HL. 1990. The effect of red blood cells on the ADP-induced aggregation of human platelets in flow through tubes. Thromb Haemost 63:112-121.
6. Bonomini M, Sirolli V, Merciaro G, Antidormi T, Di Liberato L, Brummer U, Papponetti M, Cappelli P, Di Gregorio P, Arduini A. 2005. Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine. Nephrol Dial Transplant 20:361-366.
7. Bozzo J, Hernandez MR, Ordinas A. 1995. Reduced red cell deformability associated with blood flow and platelet activation: Improved by dipyridamole alone or combined with aspirin. Cardiovasc Res 30:725-730.
8. Casati S, Passerini P, Campise MR, Graziani G, Cesana B, Perisic M, Ponticelli C. 1987. Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis. Br Med J (Clin Res Ed) 295:1017-1020.
9. Cases A, Escolar G, Reverter JC, Garrido M, Ordinas A, Lopez-Pedret J, Castillo R, Revert L. 1990. Effects of the treatment with human recombinant erythropoietin on primary hemostasis in uremic patients. Med Clin (Barc) 95:644-647.
10. Cole DJ, Connolly RJ, Chan MW, Schwaitzberg SD, Byrne TK, Adams DB, Baron PL, O'Brien PH, Metcalf JS, Demcheva M, Vournakis J. 1999. A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formulation as a topical hemostatic agent. Surgery 126:510-517.
11. Connolly RJ. 2004. Application of the poly-N-acetyl glucosamine-derived rapid deployment hemostat trauma dressing in severe/lethal Swine hemorrhage trauma models. J Trauma 57(1 Suppl):S26-S28.
12. Dhermy D, Garbarz M, Lecomte MC, Feo C, Bournier O, Chaveroche I, Gautero H, Galand C, Boivin P. 1986. Hereditary elliptocytosis: Clinical, morphological and biochemical studies of 38 cases. Nouv Rev Fr Hematol 28:129-140.
13. Falini G, Fermani S. 2004. Chitin mineralization. Tissue Eng 10:1-6.
14. Fischer TH, Connolly R, Thatte HS, Schwaitzberg SS. 2004a. Comparison of structural and hemostatic properties of the poly-N-acetyl glucosamine Syvek patch with products containing chitosan. Microsc Res Tech 63:168-174.
15. Fischer TH, Robbins ME, Bode AP, Nichols TC, Bellinger DE, Schoenfisch MH. 2004b. Evidence that rehydrated, lyophilized red blood cells are sufficiently deformable for normal microcirculation transit. Microsc Res Tech 65:62-71.
16. Fischer TH, Bode AP, Demcheva M, Vournakis JN. 2007. Hemostatic properties of glucosamine-based materials. J Biomed Mater Res A 80:167-174.
17. Fischer TH, Valeri CR, Smith CJ, Scull CM, Merricks EP, Nichols TC, Demcheva M, Vournakis JN. 2008. Non-classical processes in surface hemostasis: Mechanisms for the poly-N-acetyl glucosamine-induced alteration of red blood cell morphology and surface prothrombogenicity. Biomed Mater 3:015009.
18. Gerrard JM, Docherty JC, Israels SJ, Cheang MS, Bishop AJ, Kobrinsky NL, Schroeder ML, Israels ED. 1989. A reassessment of the bleeding time: Association of age, hematocrit, platelet function, von Willebrand factor, and bleeding time thromboxane B2 with the length of the bleeding time. Clin Invest Med 12:165-171.
19. Gladwin MT, Crawford JH, Patel RP. 2004. The biochemistry of nitric oxide, nitrite, and hemoglobin: Role in blood flow regulation. Free Radic Biol Med 36:707-717.
20. Goldsmith HL, Bell DN, Spain S, McIntosh FA. 1999. Effect of red blood cells and their aggregates on platelets and white cells in flowing blood. Biorheology 36:461-468.
21. Helley D, Eldor A, Girot R, Ducrocq R, Guillin MC, Bezeaud A. 1996. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia. Thromb Haemost 76:322-327.
22. Herold S. 2003. Interaction of nitrogen monoxide with hemoglobin and the artefactual production of S-nitroso-hemoglobin. C R Biol 326:533-541.
23. Iuliano L, Violi F, Pedersen JZ, Pratico D, Rotilio G, Balsano F. 1992. Free radical-mediated platelet activation by hemoglobin released from red blood cells. Arch Biochem Biophys 299:220-224.
24. Jewelewicz DD, Cohn SM, Crookes BA, Proctor KG. 2003. Modified rapid deployment hemostat bandage reduces blood loss and mortality in coagulopathic pigs with severe liver injury. J Trauma 55:275-280; discussion 280-281.
25. Jordan A, David T, Homer-Vanniasinkam S, Graham A, Walker P. 2004. The effects of margination and red cell augmented platelet diffusivity on platelet adhesion in complex flow. Biorheology 41:641-653.
26. King DR, Cohn SM, Proctor KG. 2004. Modified rapid deployment hemostat bandage terminates bleeding in coagulopathic patients with severe visceral injuries. J Trauma 57:756-759.
27. Luthje J. 1989. Extracellular adenine compounds, red blood cells and haemostasis: Facts and hypotheses. Blut 59:367-374.
28. Meiselman HJ. 1981. Morphological determinants of red cell deformability. Scand J Clin Lab Invest Suppl 156:27-34.
29. Mohandas N, Chasis JA. 1993. Red blood cell deformability, membrane material properties and shape: Regulation by transmembrane, skeletal and cytosolic proteins and lipids. Semin Hematol 30:171-192.
30. Mohandas N, Winardi R, Knowles D, Leung A, Parra M, George E, Conboy J, Chasis J. 1992. Molecular basis for membrane rigidity of hereditary ovalocytosis. A novel mechanism involving the cytoplasmic domain of band 3. J Clin Invest 89:686-692.
31. Muller H, Schmidt U, Lutz HU. 1981. On the mechanism of red blood cell shape change and release of spectrin-free vesicles. Acta Biol Med Ger 40:413-417.
32. Nader RG, Garcia JC, Drushal K, Pesek T. 2002. Clinical evaluation of SyvekPatch in patients undergoing interventional. EPS and diagnostic cardiac catheterization procedures. J Invasive Cardiol 14:305-307.
33. Najjar SF, Healey NA, Healey CM, McGarry T, Khan B, Thatte HS, Khuri SF. 2004. Evaluation of poly-N-acetyl glucosamine as a hemostatic agent in patients undergoing cardiac catheterization: A double-blind, randomized study. J Trauma 57(1 Suppl):S38-S41.
34. Percot A, Viton C, Domard A. 2003. Optimization of chitin extraction from shrimp shells. Biomacromolecules 4:12-18.
35. Peyrou V, Lormeau JC, Herault JP, Gaich C, Pfliegger AM, Herbert JM. 1999. Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost 81:400-406.
36. Ponder E. 1948. Hemolysis and related phenomena. Edinburgh, UK: Churchill Livingstone.
37. Ratnoff OD, Rosenblum JM. 1958. Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition. Am J Med 25:160-168.
38. Reardon DM, Seymour CA, Cox TM, Pinder JC, Schofield AE, Tanner MJ. 1993. Hereditary ovalocytosis with compensated haemolysis. Br J Haematol 85:197-199.
39. Reinhart WH, Chien S. 1986. Red cell rheology in stomatocyte-echinocyte transformation: Roles of cell geometry and cell shape. Blood 67:1110-1118.
40. Reinhart WH, Chien S. 1987. Echinocyte-stomatocyte transformation and shape control of human red blood cells: Morphological aspects. Am J Hemato l24:1-14.
41. Ruf A, Pick M, Deutsch V, Patscheke H, Goldfarb A, Rachmilewitz EA, Guillin MC, Eldor A. 1997. In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol 98:51-56.
42. Sampei K, Ulatowski JA, Asano Y, Kwansa H, Bucci E, Koehler RC. 2005. Role of nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion. Am J Physiol Heart Circ Physiol 289:H1191-H201.
43. Saniabadi AR, Lowe GD, Madhok R, Spowart K, Shaw B, Barbenel JC, Forbes CD. 1987. Red blood cells mediate spontaneous aggregation of platelets in whole blood. Atherosclerosis 66:175-180.
44. Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Eiroa AM, Aznar J. 1991. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest 87:571-580.
45. Scarborough DE, Mason RG, Dalldorf FG, Brinkhous KM. 1969. Morphologic manifestations of blood-solid interfacial reactions. A scanning and transmission electron microscopic study. Lab Invest 20:164-169.
46. Setty BN, Rao AK, Stuart MJ. 2001. Thrombophilia in sickle cell disease: The red cell connection. Blood 98:3228-3233.
47. Tachev KD, Danov KD, Kralchevsky PA. 2004. On the mechanism of stomatocyte-echinocyte transformations of red blood cells: experiment and theoretical model. Colloids Surf B Biointerfaces 34:123-140.
48. Tangelder GJ, Teirlinck HC, Slaaf DW, Reneman RS. 1985. Distribution of blood platelets flowing in arterioles. Am J Physiol 248(3 Pt 2):H318-H323.
49. Taylor JE, McLaren M, Henderson IS, Belch JJ, Stewart WK. 1992. Prothrombotic effect of erythropoietin in dialysis patients. Nephrol Dial Transplant 7:235-239.
50. Turitto V, Weiss H. 1980. Red blood cells: Their dual role in thrombosis formation. Science 207:541-543.
51. Uijttewaal WS, Nijhof EJ, Bronkhorst PJ, Den Hartog E, Heethaar RM. 1993. Near-wall excess of platelets induced by lateral migration of erythrocytes in flowing blood. Am J Physiol 264(4 Pt 2):H1239-H1244.
52. Valeri CR, Crowley JP, Loscalzo J. 1998. The red cell transfusion trigger: Has a sin of commission now become a sin of omission? Transfusion 38:602-610.
53. Valeri CR, Khuri S, Ragno G. 2007. Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: Role of temperature, red blood cells, platelets, and plasma-clotting proteins. Transfusion 47(4 Suppl):206S-248S.
54. Valles J, Santos MT, Aznar J, Marcus AJ, Martinez-Sales V, Portoles M, Broekman MJ, Safier LB. 1991. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood 78:154-162.
55. Vournakis JN, Demcheva M, Whitson AB, Finkielsztein S, Connolly RJ. 2003. The RDH bandage: hemostasis and survival in a lethal aortotomy hemorrhage model. J Surg Res 113:1-5.
56. Vournakis JN, Demcheva M, Whitson A, Guirca R, Pariser ER. 2004. Isolation, purification, and characterization of poly-N-acetyl glucosamine use as a hemostatic agent. J Trauma 57(1 Suppl):S2-S6.
57. Vroman L. 1964. Effects of hydrophobic surfaces upon blood coagulation. Thromb Diath Haemorrh 10:455-493.
58. Vroman L, Adams AL, Fischer GC, Munoz PC. 1980. Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood 55:156-159.
59. Wang L, Olivecrona G, Gotberg M, Olsson ML, Winzell MS, Erlinge D. 2005. ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells. Circ Res 96:189-196.
60. Wong P. 1999. A basis of echinocytosis and stomatocytosis in the disc-sphere transformations of the erythrocyte. J Theor Biol 196:343-361.
61. Yasin Z, Witting S, Palascak MB, Joiner CH, Rucknagel DL, Franco RS. 2003. Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F. Blood 102:365-370.
62. Zaoui P, Bayle F, Maurizi J, Foret M, DalSoglio S, Vialtel P. 1988. Early thrombosis in kidney grafted into patient treated with erythropoietin. Lancet 2:956.
63. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997;89:1121-1132.